Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.

Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE

Original Publication: Seoul, Korea : Korean Cancer Association,

Carcinoma, Hepatocellular*/diagnostic imaging ; Carcinoma, Hepatocellular*/pathology ; Liver Neoplasms*/diagnostic imaging ; Liver Neoplasms*/pathology; Male ; Humans ; Female ; Middle Aged ; Contrast Media ; Gadolinium DTPA ; Magnetic Resonance Imaging/methods ; Sensitivity and Specificity ; Republic of Korea ; Retrospective Studies

Purpose: The aim of the present study was to evaluate the per-lesion sensitivity and specificity of the Korean Liver Cancer Association-National Cancer Center (KLCA-NCC) 2022 criteria for the noninvasive diagnosis of hepatocellular carcinoma (HCC), with intraindividual comparison of the diagnostic performance of magnetic resonance imaging with extracellular agents (ECA-MRI) and hepatobiliary agents (HBA-MRI).
Materials and Methods: Patients at high risk for HCC who were referred to a tertiary academic institution for hepatic lesions with size ≥ 10 mm between July 2019 and June 2022 were enrolled. A total of 91 patients (mean age, 58.1 years; 76 men and 15 women) with 118 lesions who underwent both ECA-MRI and HBA-MRI were eligible for final analysis. The per-lesion sensitivities and specificities of the KLCA-NCC 2022 criteria using ECA-MRI and HBA-MRI were compared using McNemar's test.
Results: The 118 lesions were 93 HCCs, 4 non-HCC malignancies, and 21 benign lesions. On HBA-MRI, the "definite" HCC category showed significantly higher sensitivity than ECA-MRI (78.5% vs. 58.1%, p < 0.001), with identical specificity (92.0% vs. 92.0%, p > 0.999). For "probable" or "definite" HCC categories, there were no differences in the sensitivity (84.9% vs. 84.9%, p > 0.999) and specificity (84.0% vs. 84.0%, p > 0.999) between ECA-MRI and HBA-MRI.
Conclusion: The "definite" HCC category of the KLCA-NCC 2022 criteria showed higher sensitivity in diagnosing HCC on HBA-MRI compared with ECA-MRI, without compromising specificity. There were no significant differences in the sensitivity and specificity of "probable" or "definite" HCC categories according to ECA-MRI and HBA-MRI.

Radiology. 2018 Jan;286(1):29-48. (PMID: 29166245)
J Hepatol. 2019 Jan;70(1):151-171. (PMID: 30266282)
Hepatol Int. 2017 Jul;11(4):317-370. (PMID: 28620797)
Clin Mol Hepatol. 2022 Oct;28(4):583-705. (PMID: 36263666)
Eur Radiol. 2020 Sep;30(9):4762-4771. (PMID: 32333148)
Eur Radiol. 2021 Jul;31(7):4492-4503. (PMID: 33409787)
Eur Radiol. 2015 Oct;25(10):2859-68. (PMID: 25773941)
Korean J Radiol. 2021 Jul;22(7):1066-1076. (PMID: 33739633)
Hepatology. 2018 Aug;68(2):723-750. (PMID: 29624699)
Hepatol Int. 2020 Jul;14(4):534-543. (PMID: 32314171)
J Liver Cancer. 2020 Sep;20(2):120-127. (PMID: 37384315)
AJR Am J Roentgenol. 2017 Mar;208(3):544-551. (PMID: 28026208)
Clin Mol Hepatol. 2020 Jul;26(3):340-351. (PMID: 32492765)
Liver Int. 2021 Jul;41(7):1641-1651. (PMID: 33503328)
Clin Mol Hepatol. 2019 Sep;25(3):245-263. (PMID: 30759967)
Diagnostics (Basel). 2021 Sep 25;11(10):. (PMID: 34679461)
J Hepatol. 2018 Jul;69(1):182-236. (PMID: 29628281)
Eur Radiol. 2021 Jul;31(7):4751-4763. (PMID: 33389037)
Korean J Radiol. 2019 Jul;20(7):1042-1113. (PMID: 31270974)
Radiology. 2011 Jun;259(3):730-8. (PMID: 21364083)

Keywords: Gadolinium; Hepatocellular carcinoma; Magnetic resonance imaging; Radiology

0 (Contrast Media)
K2I13DR72L (Gadolinium DTPA)

Date Created: 20230215 Date Completed: 20230714 Latest Revision: 20230729

20250114

PMC10372598

10.4143/crt.2022.1645

36791769